Screener
Xeris Biopharma Holdings, Inc. XERS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s net margin?
- Xeris Biopharma Holdings, Inc. (XERS) reported net margin of -5.1% in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s net margin changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s net margin increased by 60.7% year-over-year, from -13% to -5.1%.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s net margin?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s net margin has grown at a -83.4% compound annual growth rate (CAGR), from -247.5% to 0.2%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Xeris Biopharma Holdings, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude